LAS41003

DRUG3 trials

Sponsors

Almirall, S.A.

Conditions

CandidiasisEczemaTinea Pedis

Phase 2

Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

CompletedNCT01020994

Almirall, S.A.Eczema

Start: 2009-11-30End: 2010-06-30Target: 150Updated: 2010-07-09

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

CompletedNCT01096472

Almirall, S.A.Tinea Pedis

Start: 2010-02-28End: 2010-06-30Updated: 2012-07-09

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

CompletedNCT01102387

Almirall, S.A.Candidiasis

Start: 2010-02-28End: 2011-07-31Updated: 2012-07-04